Hims is already knocking off Novo's Wegovy pill
Digest more
By comparison, Novo Nordisk’s Wegovy pill—launched earlier this year and already used by more than 170,000 people, CEO Mike ...
NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health will begin offering copies of Novo Nordisk's new ...
With just a few months to go before Eli Lilly expects to launch its own oral GLP-1 obesity drug, Novo Nordisk is making the ...
Oral Wegovy shifts GLP-1 obesity costs: insurance may match injectables, while cash-pay and pharmacy platforms unlock lower prices and aid programs.
Novo Nordisk CEO Maziar Mike Doustdar acknowledged the market pressure facing the company’s GLP-1 products but sought to ...
The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results